Percutaneous decannulation | n = 20 |
---|---|
Patient's characteristics | |
Age (years) | 60 (27–76) |
Cardiac arrest (n) | 11 |
Ressuscitated cardiac arrest | 10 |
Refractory cardiac arrest | 1 |
STEMI (n) | 13 |
LVEF (%)a | 15 (5–45) |
SOFA score | 8 (3–14) |
ECMO duration (days) | 6 (2–16) |
Decannulation procedure | |
Cross-over (n) | 17 |
Technical success (n) | 19 |
Need of covered stent implantation for hemostasis (n) | 0 (0) |
Fluoroscopy time (min) | 6.5 (2.1–19.6) |
Iodinated contrast volume (mL) | 25 (10–140) |
Dose area product (cGy/cm2) | 1236 (249–4277) |
Cumulated air karma (mGy) | 140 (23–423) |
Outcomes | |
30-day mortality (n) (%) | 11 (55%) |
ICU stay (days) | 21 (5–47) |
Significant vascular complications (n) | 1 |
Need for surgical closure (n) | 1 |
Acute lower limb ischemia (n) | 0 |
Significant bleeding (n) | 0 |
Groin infection (n) | 0 |